Bill Text: WA HB1689 | 2021-2022 | Regular Session | Chaptered


Bill Title: Exempting biomarker testing from prior authorization for patients with late stage cancer.

Spectrum: Slight Partisan Bill (Democrat 6-2)

Status: (Passed) 2022-03-24 - Effective date 6/9/2022. [HB1689 Detail]

Download: Washington-2021-HB1689-Chaptered.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.
feedback